Groove Health, a Chicago, IL-based digital health startup has raised $1.6 million to help expand its data-driven medication adherence platform for health insurance companies, hospital systems, and self-insured employers. Investors of the seed round were not disclosed.
Founded in 2016, Groove Health partners with healthcare enterprises to provide value-added analytical insights and targeted outreach programs that increase medication adherence rates in chronically-ill populations. The company’s proprietary analytics platform combines existing healthcare data with patient-generated data from its mobile app and other sources to create a comprehensive understanding of each patient’s unique adherence profile.
Groove then implements its patient engagement program, which leverages a mobile app and other forms of outreach, to influence health-positive behaviors in high-risk patients.The combined platform integrates directly into the enterprise workflow, improves the efficiency of existing care teams, and provides organizations with new methods of engaging patients.
Each year in the U.S., poor medication adherence causes 30-50% of treatment failures, 125,000 deaths, and over $100 billion of avoidable healthcare spending. A recent study found that 26% of hospital readmissions were potentially preventable and medication-related.1 The Centers for Medicare & Medicaid Services (“CMS”) and the National Committee for Quality Assurance (“NCQA”) incorporate medication adherence measures in their Star Ratings programs, which measure health plans’ performance on important dimensions of care and service.
“Medication adherence is a major challenge in healthcare today, with significant implications for medical outcomes,” said Andrew Hourani, Groove Health’s Founder and CEO in a statement. “Interestingly enough, adherence is a behavioral issue, not a medical one. At Groove Health, our interest lies at the intersection of data analysis and behavioral psychology. How can aggregated data help us identify the causative factors of non-adherence, and how can we influence patient behavior accordingly?”
